Platelet serotonin 2A (5-HT2A) receptor characteristics and parenting factors for boys at risk for delinquency: A preliminary report

American Journal of Psychiatry

Volumn 153, Issue 4, 1996, Pages 538-544

  Pine, Daniel S ^a   Wasserman, Gail A ^b   Coplan, Jeremy ^b   Fried, Jane A ^b   Huang, Yung Yu ^b   Kassir, Suham ^b   Greenhill, Laurence ^b   Shaffer, David ^b   Parsons, Bruce ^b  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LYSERGIDE; SEROTONIN; SEROTONIN 2A RECEPTOR; TRITIUM;

ANTISOCIAL BEHAVIOR; ARTICLE; CHILD; CHILD PARENT RELATION; CLINICAL ARTICLE; FAMILY HISTORY; HUMAN; HUMAN CELL; JUVENILE DELINQUENCY; MALE; PRIORITY JOURNAL; REARING; RECEPTOR AFFINITY; RECEPTOR DENSITY; THROMBOCYTE MEMBRANE;

ANTISOCIAL PERSONALITY DISORDER; BLOOD PLATELETS; CHILD; CHILD ABUSE; HUMANS; JUVENILE DELINQUENCY; LYSERGIC ACID DIETHYLAMIDE; MALE; MENTAL DISORDERS; PARENT-CHILD RELATIONS; PARENTING; PROSPECTIVE STUDIES; PUNISHMENT; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RISK FACTORS; SEASONS; SEROTONIN; SOCIAL CONTROL, FORMAL; SUBSTANCE-RELATED DISORDERS; TRITIUM;

EID: 0029898096     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.4.538     Document Type: Article

References (40)

1. Zubieta JK, Alessi NE: Is there a role of serotonin in the disruptive behavior disorders? a literature review. J Child and Adolescent Psychopharmacology 1993; 3:11-35
2. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 1994; 36:326-337
3. Coccaro E, Siever L, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL: Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 1989; 46:587-599
4. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M: CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994; 51:20-27
5. Kruesi MJ, Hibbs ED, Zahn TP, Keysor CS, Hamburger SD, Bartko JJ, Rapoport JL: A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders: prediction by ccrebrospinal fluid 5-hydroxyindoleacetic acid, homovanillc acid, and autonomie measures? Arch Gen Psychiatry 1992; 49:429-435
6. Castellanos FX, Eha J, Kruesi MJP, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF, Rapoport JL: Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res 1994; 52:305-316
7. Stoff DM, Pasatiempo AP, Yeung J, Cooper TC, Bridger WH, Rabinovich H: Neuroendocrine responses to challenges with dlfenfluramine and aggression in disruptive behavior disorders of children and adolescents. Psychiatry Res 1992; 43:263-276
8. Halperin JM, Sharma V, Siever LJ, Schwanz ST, Matier K, Wornell G, Newcorn JH: Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry 1994; 151:243-248
9. Birmaher B, Stanley M, Greenhill L, Twomey J, Gavrilescu A, Rabinovich H: Platelet imipramine binding in children and adolescents with impulsive behavior. J Am Acad Child Adolesc Psychiatry 1990; 29:914-918
10. Stoff DM, Pollock L, Vitiello BD, Bridger WH: Reduction of 3H-imipramine binding sites on platelets of conduct-disordered children. Neuropsychopharmacology 1987; 1:55-62
11. Weizman A, Benhout E, Weitz R, Tyano S, Rehavi M: Imipramine binding to platelets of children with attention-deficit disorder with hyperactivity. Biol Psychiatry 1988; 23:491-496
12. Stoff DM, Iem J, Friedman E, Bridger WH, Pollock L, Vitiello B: Platelet 3H-imipramine binding, serotonin uptake, and plasma alpha 1 acid glycoprotein in disruptive behavior disorders. Biol Psychiatry 1991; 29:494-498
13. Blumensohn R, Ratzoni G, Weizman A, Israeli M, Greuner N, Apter A, Tyano S, Biegon A: Reduction in serotonin 5HT2 receptor binding on platelets of delinquent adolescents. Psychopharmacology (Berl) 1995; 118:354-356
14. Pandey GN, Pandey SC, Dwivedi Y, Sharma RP, Janicak PG, Davis JM: Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am J Psychiatry 1995; 152:850-855
15. 3H]imipramine binding in adolescents who attempted suicide. Am J Psychiatry 1995; 152:923-925
16. Hanna G, Yuwiler A, Coates JK: Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:28-35
17. Brewton TD: Seasonal variations of serotonin functions in humans: research and clinical implications. Ann Clin Psychiatry 1989; 1:153-164
18. Mann JJ, McBride PA, Brown RP, Lmnoila M, Leon AC, DeMeo M, Mieczkowski T, Myers J, Stanley M: Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 1992; 49:442-446
19. Cook EH, Fletcher KE, Marks N, Wainwright M, Yan S, Leventhal BL: Identity of the primary structure of the human platelet and brain 5-HT2A receptors. J Neurochem 1994; 63:465-469
20. Ostrowitzki S, Rao ML, Redei J, Andres AH: Concurrence of cortex and platelet serotonin-2 receptor binding characteristics in the individual and putative regulation by serotonin. J Neural Transm 1993; 93:27-35
21. Ernouf D, Compagnon P, Lothion P, Narcisse G, Bénard JY, Daoust M: Platelet 3H 5-HT uptake in descendants from alcoholic patients: a potential risk factor for alcohol dependence? Life Sci 1993; 52:989-995
22. Coccaro EF, Silverman JM, Klar HM, Horvath TB, Siever LJ: Family correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry 1994; 51:318-324
23. Rosenblum LA, Coplan JD, Bassoff T, Gorman JM, Andrews MW: Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry 1992; 32: 127-145
24. Rosenblum LA: Human aggression: a perspective drawn from non-human primates, in Rage, Power, and Aggression. Edited by Glick RA, Roose SP. New Haven, Conn, Yale University Press, 1993, pp 194-211
25. Rutter R, Giller H: Juvenile Delinquency: Trends and Perspectives. New York, Guilford Press, 1984
26. Lewis DL: From abuse to violence: psychophysiological consequences of maltreatment. J Am Acad Child Adolesc Psychiatry 1992; 31:383-391
27. Cohcn P, Brook J: Family factors related to the persistence of psychopathology in childhood and adolescence. Psychiatry 1987; 50:332-345
28. Davis DD, Dunlop SR, Shea P, Brittain H, Hendrie HC: Biological stress responses in high and low trait anxious students. Biol Psychiatry 1985; 20:843-851
29. Iny LJ, Pecknold J, Suranyi-Cadotte BE, Bernier B, Luthe L, Nair NPV, Meaney MJ: Studies of a neurochemical link between depression, anxiety, and stress from 3H-imipramine and 3H-pa-roxetine binding on human platelets. Biol Psychiatry 1994; 36: 281-291
30. Achenbach TM: Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington, University of Vermont, Department of Psychiatry, 1991
31. Shaffer D, Schwab-Stone M, Fisher P, Cohen P, Piacentim J, Davies M, Connors CK, Regier D: The Diagnostic Interview Schedule for Children-Revised Version (DISC-R), I: preparation, field testing, interrater reliability, and acceptability. J Am Acad Child Adolesc Psychiatry 1993; 32:643-650
32. Lisch JD, Weissman MM, Adams PB, Hoven CW, Bird H: Family psychiatric screening instrument: pilot testing and validation. Psychiatry Res 1995; 57:169-180
33. Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA: Adoption study demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry 1995; 52:42-52
34. Raine A: The Psychopathology of Crime. New York, Academic Press, 1993
35. Bradley RH: The HOME Inventory: rationale and research, in Recent Research in Developmental Psychopathology: Journal of Child Psychology and Psychiatry Supplement 4. Edited by Stevenson J. Oxford, England, Pergamon Press, 1985, pp 191-201
36. Lowry OH, Rowenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275
37. Arora RC, Meltzer HY: Seasonal variation of imipramme binding in the blood platelets of normal controls and depressed patients. Biol Psychiatry 1988; 217-226
38. Daoust M, Lhuintre JP, Ernouf D, Legrand E, Breton P, Boucly P: Ethanol intake and 3H-serotonin uptake, II: a study in alcoholic patients using platelet 3H-paroxetine binding. Life Sci 1991; 48:1977-1983
39. Higley JD, Suomi SJ, Linnoila M: CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the Stressor of social separation in rhesus monkeys. Psychopharmacology (Berl) 1991; 103:551-556
40. Cook EH, Arora RC, Andersen FM, Berry-Kravis EM, Yan S, Yeaoh HC, Sklena PJ, Charak DA, Leventhal BL: Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 1993; 52:2005-2015